Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Astrolabe Analytica, legally known as Astrolabe Diagnostics, is a bioinformatics company providing a cloud-based platform for the automated analysis of single-cell data. The company's technology streamlines the processing of high-dimensional datasets from flow cytometry, mass cytometry (CyTOF), and single-cell RNA sequencing. By automating cell subset identification and statistical analysis, the platform allows researchers to move from raw data to biological insights with significantly reduced manual effort. Astrolabe's solutions are tailored for use in immunology, oncology, and infectious disease research, supporting both basic science and clinical trial monitoring. The platform is used by a wide range of clients, including major pharmaceutical companies, biotechnology startups, and leading academic institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Astrolabe Analytica.